JENNY USHERWOOD: Open Payments
NPI 1225370406 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 14 payments from 7 companies in 2025. Trend: 2023 $426 · 2024 $472 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $161 |
| ViiV Healthcare Company | 2 | $112 |
| Melinta Therapeutics, LLC | 2 | $45 |
| ABBVIE INC. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Shionogi Inc | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: CABENUVA, PIFELTRO, Rezzayo, PREVYMIS, CAPVAXIVE, EMBLAVEO, CUVITRU, APRETUDE.
Industry payments across GA — which companies pay providers there.
